Literature DB >> 21680201

Use of a retrievable vena cava filter with low-intensity anticoagulation for prevention of pulmonary embolism in patients with cancer: an observational study in 106 cases.

Bruno Damascelli1, Vladimira Ticha, Gianluigi Patelli, Rodolfo Lanocita, Carlo Morosi, Enrico Civelli, Giuseppe Di Tolla, Laura Francesca Frigerio, Elisa Ciceri, Francesco Garbagnati, Carlo Spreafico, Paola Amadeo, Alfonso Marchianò.   

Abstract

PURPOSE: To evaluate a retrievable inferior vena cava (IVC) filter in combination with low-intensity oral anticoagulation for prevention of pulmonary embolism (PE) in patients with malignancy complicated by thromboembolic disease.
MATERIALS AND METHODS: From October 2005 to December 2009, 107 Bard G2 filters were placed in 106 patients. Forty-eight patients had deep vein thrombosis (DVT) alone, 53 had PE with DVT, and five had PE with no evidence of DVT. After an initial period of anticoagulation with heparin, low-intensity oral anticoagulant therapy to achieve a target International Normalized Ratio of 1.5-2.0 was instituted. Follow-up computed tomography to evaluate the pulmonary circulation, IVC, and lower limbs was performed at 3 and 6 months.
RESULTS: PE recurred in three of 58 patients (5.2%). None of the 48 patients with DVT alone developed PE, nor was there any recurrence of DVT. The filter was removed in 14 patients (13.2%). No complications occurred during the retrieval procedure. A total of 16 complications occurred in seven patients: one migration (0.9%); four cases of vena cava thrombosis (3.7%), three of which were associated with recurrent PE (2.8%); one filter fracture (0.9%); and one IVC penetration (0.9%). Filter tilting greater than 15° occurred in six patients (5.7%) and was associated with other complications in five (4.7%).
CONCLUSIONS: In patients with malignancies complicated by venous thromboembolic disease, an IVC filter together with low-intensity anticoagulation may be a possible treatment strategy for PE prophylaxis. Controlled studies are warranted.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21680201     DOI: 10.1016/j.jvir.2011.04.015

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  5 in total

Review 1.  Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus.

Authors:  Mariasanta Napolitano; Giorgia Saccullo; Marco Marietta; Monica Carpenedo; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Valerio De Stefano; Anna Falanga; Augusto B Federici; Elena Rossi; Rita Santoro; Sergio Siragusa; Valerio De Stefano; Anna Falanga; Alberto Tosetto; Giuseppe Avvisati; Monica Carpenedo; Augusto B Federici; Marco Marietta; Mariasanta Napolitano; Elena Rossi; Cristina Santoro; Giancarlo Castaman; Elisabetta Cerchiara; Antonio Chistolini; Laura Contino; Maria Gabriella Mazzucconi; Ilaria Nichele; Laura Russo; Roberto Santi; Rita Carlotta Santoro; Sergio Siragusa; Giuseppe Tagariello
Journal:  Blood Transfus       Date:  2018-10-24       Impact factor: 3.443

2.  Retrievable inferior vena cava filters in patients with cancer are safe but are they beneficial?

Authors:  Sameh Mikhail; Lindsay Hannan; Michael J Pishvaian; Craig Kessler
Journal:  Med Oncol       Date:  2015-04-29       Impact factor: 3.064

3.  Inferior vena cava filters for primary prophylaxis: when are they indicated?

Authors:  Eric Wehrenberg-Klee; S William Stavropoulos
Journal:  Semin Intervent Radiol       Date:  2012-03       Impact factor: 1.513

4.  Outcome of anticoagulation with rivaroxaban in patients with non-retrieved inferior vena cava filters for the prevention of filter thrombosis: a retrospective cohort study.

Authors:  Baoyan Wang; Chenxiao Jiang; Yepeng Zhang; Xiaoqiang Li; Hang Xu
Journal:  BMC Cardiovasc Disord       Date:  2022-09-11       Impact factor: 2.174

5.  Three-year experience of prophylactic placement of inferior vena cava filters in women with gynecological cancer.

Authors:  Suresh B Babu; Asiya Maheen Khan; Philip Jb Coates
Journal:  Int J Gen Med       Date:  2013-08-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.